HCA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
HCA Healthcare Inc is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The company demonstrates strong financial performance, positive analyst sentiment, and long-term growth potential, despite short-term price weakness and insider selling.
The stock's MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 48.177, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its key support level (S1: 524.372), which could act as a potential entry point.
HCA Healthcare has been ranked No. 1 in its industry on Fortune's 2026 World's Most Admired Companies list. The company is expanding its research institute and providing significant tuition assistance to employees, reflecting strong leadership and operational growth. Analysts have raised price targets significantly, citing AI-driven efficiency gains and strong financial performance.
Insiders are selling heavily, with a 1487.91% increase in selling activity over the last month. The stock has experienced a -2.72% regular market change, and short-term technical indicators suggest bearish momentum.
In Q4 2025, revenue increased by 6.72% YoY to $19.51 billion, net income rose by 30.60% YoY to $1.878 billion, EPS grew by 44.58% YoY to 8.14, and gross margin improved slightly to 80.07%. These figures indicate strong financial health and growth.
Analysts are overwhelmingly positive, with multiple firms raising price targets significantly. UBS raised its target to $635, Mizuho to $585, and Cantor Fitzgerald to $588, citing strong fundamentals, efficiency initiatives, and AI-driven growth potential. However, Bernstein remains cautious, citing high valuations and potential EBITDA growth headwinds.
